Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on November 9, 2026

Nov. 9, 2026

J-Star Holding Co., Ltd. Highlights U.S. Operational Progress with Delegation Visit from Global Tier 1 Carbon Fiber Manufacturer

Indeterminate GlobeNewswire

Nov. 9, 2026

Marengo Presents Interim Phase 2 STARt-002 Results for First-in-Class Selective T-Cell Agonist Invikafusp Alfa Plus Sacituzumab Govitecan Across Two Metastatic Breast Cancer Cohorts in Oral Presentation at SITC 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

Tonix Pharmaceuticals Reports Third Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire

Nov. 9, 2026

Hemab Therapeutics Initiates SOLARA, a Pivotal Phase 3 Trial of Sutacimig in Glanzmann Thrombasthenia

Indeterminate GlobeNewswire

Nov. 9, 2026

Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2026 on the Potential of MRT-8102 in Gout

Indeterminate GlobeNewswire

Nov. 9, 2026

Editas Medicine Announces Third Quarter 2026 Results and Business Updates

Indeterminate GlobeNewswire

Nov. 9, 2026

Nkarta Announces Initial Clinical Data for NKX019 in Myositis and Systemic Sclerosis at ACR Convergence

Indeterminate GlobeNewswire

Nov. 9, 2026

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2026, and Provides Business Update

Indeterminate GlobeNewswire

Nov. 9, 2026

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2026 Financial Results 

Indeterminate GlobeNewswire

Nov. 9, 2026

Ocular Therapeutix™ Reports Third Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

Nov. 9, 2026

Atea Pharmaceuticals Secures Credit Facility for Up to $200 Million from Hercules Capital

Indeterminate GlobeNewswire

Nov. 9, 2026

Annovis Announces Closing of $21.0 Million Public Offering with 24% Contribution from the Board Chairman

Indeterminate GlobeNewswire

Nov. 9, 2026

Kamada Declares Cash Dividend of $0.14 Per Share; The Company Continues its Record-High Year

Indeterminate GlobeNewswire

Nov. 9, 2026

Mentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million Financing

Indeterminate GlobeNewswire

Nov. 9, 2026

CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care

Indeterminate GlobeNewswire

Nov. 9, 2026

Tango Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights

Indeterminate GlobeNewswire

Nov. 9, 2026

BlossomHill Therapeutics Announces Outcome from the End-of-Phase 1 Meeting with the FDA and Pivotal Phase 2 Trial Design for OMNI-EGFR™ Inhibitor, BH-30643, in EGFR C797S-Positive NSCLC

Indeterminate GlobeNewswire

Nov. 9, 2026

Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended September 30, 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

Tiziana Life Sciences to Present at BIO-Europe 2026 and Host KOL Webcast

Indeterminate GlobeNewswire

Nov. 9, 2026

Can-Fite Reports Ten-Year Survival Milestone for Advanced Liver Cancer Patient from Phase II Namodenoson Study

Indeterminate GlobeNewswire